Investing.com - Incyte reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Incyte announced earnings per share of $0.55 on revenue of $733.24M. Analysts polled by Investing.com EPS of $0.458 on revenue of $750.25M.
Incyte 's are up 39.27% and is trading at $73.13 , still down 13.83% from its 52 week high of $88.26 set on Monday, June 28, 2021.
Incyte shares lost 3.84% to trade at $73.13 in pre-market trade the report.
Incyte follows other major Healthcare sector earnings this month
Incyte's report follows an earnings beat by UnitedHealth on Thursday, April 14, 2022, who reported EPS of $5.49 on revenue of $80.15B, EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on Tuesday, April 19, 2022 with first quarter EPS of $2.67 on revenue of $23.43B, for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar